• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

H1 Launches AI-Powered and Evidence-Based Interactions

by Syed Hamza Sohail 08/11/2022 Leave a Comment

H1 Launches AI-Powered and Evidence-Based Interactions

What You Should Know:

– H1, launches an update to its flagship product, HCP Universe, the daily resource for global medical affairs and medical science liaison (MSL) teams.

– New features include a mobile app, Next-gen Smart Search capabilities built on an expansive knowledge graph, out-of-the-box insights tailored to inform MSL and Headquarter decisioning, and AI-powered notifications to improve and accelerate quality HCP engagement. 

Establishing AI-Driven Efficient Workflows

H1 is the connecting force for global HCP, clinical, scientific and research information. The H1 Connect platform democratizes access to HCP knowledge and groundbreaking insights for life sciences, academic medical institutions, health systems, and payors. H1 Connect fuels a robust product suite that helps customers discover and engage industry experts, drive equitable research, access groundbreaking science, and accelerate commercial success with the most robust and accurate healthcare professional data.


HCP Universe is built on the H1 Connect platform, which seamlessly blends H1 proprietary, public, industry, and self-reported HCP information and patient encounter data. The latest AI and Data Science technologies are then layered on the H1 Data Network to fit the unique workflows of key stakeholders across Pharma and Biotech companies. A subset of the AI-enabled features that will be available to customers this year include:  

1. Integration with Calendars (i.e., Outlook) and Proactive Mobile Text Notifications: A new and improved notification and alert framework that integrates with work calendars and provides proactive alerts and updates about HCPs before their next scheduled meeting. Signals include tweets, publications, congresses, and clinical trial data for initiating outreach. 

2. Smart Search and Discovery: A completely re-designed KOL network exploration interface that helps MSLs easily uncover HCP connections, identify HCPs that work well together, compare and contrast HCPs, and determine if HCPs meet certain criteria. Customizable, one-click search filters can reveal unique HCP segments like prolific publishers, early career influencers, and industry speakers. 

3. Digital Activity and Leadership Monitoring: Users can explore and understand an HCP’s social network in conjunction with their academic and research collaborations. H1 has developed a unique and AI-based technological algorithm to find Therapeutic Area (TA) digital opinion leaders (DOLs), specialized in individual areas of interest. Users can quickly identify DOLs within a given indication or TA and categorize through indexing of followers and other profile-level metadata to derive a digital leadership score.

“According to a recent study by ZS Associates, Medical Affairs leaders surveyed claim medical analytics and more specifically AI and NLP are among their top areas of investments. While H1 has long been recognized as having the most comprehensive mix of HCP data available – this evolution of our application of AI, NLP and Machine Learning transforms the way our customers extract 360-degree insights on global HCPs and KOLs and the patient populations they serve,” said Katz. “Without HCP Universe, corporate Medical Affairs teams and field MSLs are forced to spend too much time and effort consuming, analyzing, and synthesizing data for each individual engagement. Moreover, unvetted information can be outdated, incomplete or overlapping. This results in lost opportunities to connect and cultivate relationships with the right medical experts. Our revamped HCP Universe changes all that.”

Tagged With: AI, Artificial Intelligence, Biotech, Box, Clinical Trial, H1, Health Systems, Knowledge Graph, Life Sciences, Machine Learning, NLP, Pharma

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |